These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

337 related items for PubMed ID: 21078844

  • 1. Vaccination against Chlamydia genital infection utilizing the murine C. muridarum model.
    Farris CM, Morrison RP.
    Infect Immun; 2011 Mar; 79(3):986-96. PubMed ID: 21078844
    [Abstract] [Full Text] [Related]

  • 2. Intranasal vaccination with a secreted chlamydial protein enhances resolution of genital Chlamydia muridarum infection, protects against oviduct pathology, and is highly dependent upon endogenous gamma interferon production.
    Murthy AK, Chambers JP, Meier PA, Zhong G, Arulanandam BP.
    Infect Immun; 2007 Feb; 75(2):666-76. PubMed ID: 17118987
    [Abstract] [Full Text] [Related]

  • 3. A vaccine formulated with the major outer membrane protein can protect C3H/HeN, a highly susceptible strain of mice, from a Chlamydia muridarum genital challenge.
    Pal S, Tatarenkova OV, de la Maza LM.
    Immunology; 2015 Nov; 146(3):432-43. PubMed ID: 26423798
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Transcutaneous immunization with a novel lipid-based adjuvant protects against Chlamydia genital and respiratory infections.
    Hickey DK, Aldwell FE, Beagley KW.
    Vaccine; 2009 Oct 19; 27(44):6217-25. PubMed ID: 19698810
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Intranasal vaccination with Chlamydia pneumoniae induces cross-species immunity against genital Chlamydia muridarum challenge in mice.
    Manam S, Chaganty BK, Evani SJ, Zafiratos MT, Ramasubramanian AK, Arulanandam BP, Murthy AK.
    PLoS One; 2013 Oct 19; 8(5):e64917. PubMed ID: 23741420
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Vaccination with the polymorphic membrane protein A reduces Chlamydia muridarum induced genital tract pathology.
    Müller T, Becker E, Stallmann S, Waldhuber A, Römmler-Dreher F, Albrecht S, Mohr F, Hegemann JH, Miethke T.
    Vaccine; 2017 May 15; 35(21):2801-2810. PubMed ID: 28413133
    [Abstract] [Full Text] [Related]

  • 14. Comparison of immune responses and protective efficacy of intranasal prime-boost immunization regimens using adenovirus-based and CpG/HH2 adjuvanted-subunit vaccines against genital Chlamydia muridarum infection.
    Brown TH, David J, Acosta-Ramirez E, Moore JM, Lee S, Zhong G, Hancock RE, Xing Z, Halperin SA, Wang J.
    Vaccine; 2012 Jan 05; 30(2):350-60. PubMed ID: 22075089
    [Abstract] [Full Text] [Related]

  • 15. Chlamydia muridarum T-cell antigens formulated with the adjuvant DDA/TDB induce immunity against infection that correlates with a high frequency of gamma interferon (IFN-gamma)/tumor necrosis factor alpha and IFN-gamma/interleukin-17 double-positive CD4+ T cells.
    Yu H, Jiang X, Shen C, Karunakaran KP, Jiang J, Rosin NL, Brunham RC.
    Infect Immun; 2010 May 05; 78(5):2272-82. PubMed ID: 20231405
    [Abstract] [Full Text] [Related]

  • 16. The Chlamydia M278 Major Outer Membrane Peptide Encapsulated in the Poly(lactic acid)-Poly(ethylene glycol) Nanoparticulate Self-Adjuvanting Delivery System Protects Mice Against a Chlamydia muridarum Genital Tract Challenge by Stimulating Robust Systemic and Local Mucosal Immune Responses.
    Verma R, Sahu R, Dixit S, Duncan SA, Giambartolomei GH, Singh SR, Dennis VA.
    Front Immunol; 2018 May 05; 9():2369. PubMed ID: 30374357
    [Abstract] [Full Text] [Related]

  • 17. CD4+ T cells and antibody are required for optimal major outer membrane protein vaccine-induced immunity to Chlamydia muridarum genital infection.
    Farris CM, Morrison SG, Morrison RP.
    Infect Immun; 2010 Oct 05; 78(10):4374-83. PubMed ID: 20660610
    [Abstract] [Full Text] [Related]

  • 18. Induction of protective immunity against Chlamydia muridarum intravaginal infection with the chlamydial immunodominant antigen macrophage infectivity potentiator.
    Lu C, Peng B, Li Z, Lei L, Li Z, Chen L, He Q, Zhong G, Wu Y.
    Microbes Infect; 2013 Apr 05; 15(4):329-38. PubMed ID: 23416214
    [Abstract] [Full Text] [Related]

  • 19. Nonpathogenic Colonization with Chlamydia in the Gastrointestinal Tract as Oral Vaccination for Inducing Transmucosal Protection.
    Wang L, Zhu C, Zhang T, Tian Q, Zhang N, Morrison S, Morrison R, Xue M, Zhong G.
    Infect Immun; 2018 Feb 05; 86(2):. PubMed ID: 29133348
    [Abstract] [Full Text] [Related]

  • 20. Chlamydial protease-like activity factor induces protective immunity against genital chlamydial infection in transgenic mice that express the human HLA-DR4 allele.
    Murthy AK, Cong Y, Murphey C, Guentzel MN, Forsthuber TG, Zhong G, Arulanandam BP.
    Infect Immun; 2006 Dec 05; 74(12):6722-9. PubMed ID: 17015458
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.